A trial involving 100,000 female volunteers to compare the use of traditional 2D mammograms with the new 3D breast imaging technology. The trial will measure the efficacy and cost-effectiveness of the two technologies.
Traditional mammograms create a 2D image of the breast. There is now a newer type of breast imaging technology called 'digital breast tomosynthesis' which creates a 3D image. Early indications suggest this is more effective for cancer screening.
To compare the cost-effectiveness of breast cancer screening using digital breast tomosynthesis or standard mammograms by measuring cancers identified in each group, measuring the number of cancers that are diagnosed between screening mammograms, and the size and stage of breast cancers.
What to know more?
If you have received an invitation to take part in the PROSPECTS trial and have any more…
What is it about?
Click below for more detailed information about
the PROSPECTS trial
The PROSPECTS trial team are looking to open additional trial sites over the next 6 months to help mitigate the impact of the pandemic and boost recruitment.